Anirban Sen Gupta
Education
Research Interests
Biomaterials, Nanomedicine, Hemostasis Thrombosis and Inflammatory DiseasesTeaching Interests
Biomaterials, Nanomedicine, Hemostasis Thrombosis and Inflammatory DiseasesPublications
News About Anirban Sen Gupta
Research team led by Case Western Reserve awarded $2.75M from Department of Defense to advance clot-stabilizing nanotechnology
The U.S. Department of Defense has awarded a team of researchers led by Case Western Reserve University a four-year, $2.75 million grant to explore new technology to generate and stabilize a protein called fibrin that is essential to maintain protective blood clots in an injured body. Anirban Sen Gupta, the Wallace R. Persons Endowed Professor of Engineering and professor of biomedical engineering, is leading the project with two researchers from other institutions.
National Academy of Inventors names seven Case Western Reserve University researchers to 2024 class of senior members
The National Academy of Inventors (NAI) has named seven Case Western Reserve University researchers to its 2024 class of senior members, an honor that recognizes their “remarkable innovation-producing technologies that have brought, or aspire to bring, real impact on the welfare of society.” This year’s class of NAI senior members is the largest to date and hails from 60 NAI-member institutions nationally. The Daily sat down to learn more about the seven honorees from CWRU.
Anirban Sen Gupta named Fellow of Biomaterials Science and Engineering
Receiving the highest honor among the global biomaterials community, Anirban Sen Gupta is now one of less than 500 individuals to become a Fellow of Biomaterials Science and Engineering (FBSE).
Biomedical engineer explores new use for synthetic platelets: treating inherited bleeding disorders
Even as biomedical engineer Anirban Sen Gupta refines artificial platelets to stem traumatic bleeding, he and his colleagues are seeking new uses for their synthetic solution. The latest application to show promise involves providing synthetic platelets to treat a genetic condition that prevents blood from clotting, Von Willebrand disease (VWD). The most common of all bleeding disorders, VWD is found in up to 1% of the U.S. population (roughly 3 million people), according to the Centers for Disease Control and Prevention.
Quest for blood surrogate gets $46 million boost: Case Western Reserve plays key research role
University of Maryland leads team of multiple universities and biotech companies; CWRU to evaluate and optimize synthetic blood products
Anirban Sen Gupta In the News
Cleveland plays a big role in a life-saving, ‘world-first’ medical innovation: artificial blood
Anirban Sen Gupta, the Leonard Case Jr. Professor of Engineering at Case School of Engineering, discussed his new research that seeks components that mimic the functions of real blood into something that can be freeze-dried and easily stored as powder then reconstituted on demand using saline. “That’s why this is so exciting—this could be the culmination of a century of efforts by human beings to create a substitute for whole blood,” he said.
CWRU researchers developing life-saving blood substitute to help save thousands of lives
Anirban Sen Gupta, the Leonard Case Jr. Professor of Engineering at Case School of Engineering, discussed efforts to develop groundbreaking research to save people’s lives who need blood during critical circumstances. “What we have been trying to do, for a long time, and we are continuing to do is to create a synthetic materials-based systems,” he said.
Stopping bleeding at the site at Case Western Reserve
Anirban Sen Gupta, professor of biomedical engineering, discussed his new technology “SanguiStop,” which allows a clot-promoting enzyme called thrombin to be intravenously delivered in a targeted manner to a bleeding area—especially to the site of internal injuries.